BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8498369)

  • 1. Plasma big endothelin-1 concentrations in congestive heart failure patients with or without systemic hypertension.
    Pacher R; Bergler-Klein J; Globits S; Teufelsbauer H; Schuller M; Krauter A; Ogris E; Rödler S; Wutte M; Hartter E
    Am J Cardiol; 1993 Jun; 71(15):1293-9. PubMed ID: 8498369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure.
    Pacher R; Stanek B; Hülsmann M; Koller-Strametz J; Berger R; Schuller M; Hartter E; Ogris E; Frey B; Heinz G; Maurer G
    J Am Coll Cardiol; 1996 Mar; 27(3):633-41. PubMed ID: 8606275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
    Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
    Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential big endothelin plasma levels in heart transplant recipients during bridging therapy and after successful heart transplantation.
    Strametz-Juranek J; Pacher R; Kos T; Woloszczuk W; Grimm M; Zuckermann A; Stanek B
    J Heart Lung Transplant; 2003 Jul; 22(7):731-7. PubMed ID: 12873540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of endothelin-1 at rest and after exercise in patients with moderate congestive heart failure.
    de Groote P; Millaire A; Racadot A; Decoulx E; Ducloux G
    Int J Cardiol; 1995 Oct; 51(3):267-72. PubMed ID: 8586475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superiority of big endothelin-1 and endothelin-1 over natriuretic peptides in predicting survival in severe congestive heart failure: a 7-year follow-up study.
    Van Beneden R; Gurné O; Selvais PL; Ahn SA; Robert AR; Ketelslegers JM; Pouleur HG; Rousseau MF
    J Card Fail; 2004 Dec; 10(6):490-5. PubMed ID: 15599839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of big endothelin plasma levels compared with established neurohumoral markers in patients with severe chronic heart failure.
    Stanek B; Frey B; Hülsmann M; Koller-Strametz J; Hartter E; Schuller M; Ogris E; Maurer G; Pacher R
    Transplant Proc; 1997; 29(1-2):595-6. PubMed ID: 9123146
    [No Abstract]   [Full Text] [Related]  

  • 8. Endothelin in human congestive heart failure.
    Wei CM; Lerman A; Rodeheffer RJ; McGregor CG; Brandt RR; Wright S; Heublein DM; Kao PC; Edwards WD; Burnett JC
    Circulation; 1994 Apr; 89(4):1580-6. PubMed ID: 8149524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the levels of plasma atrial natriuretic peptide, hemodynamic measurements, and the levels of vasoactive hormones during the clinical course of congestive heart failure.
    Hara H; Ogihara T; Nakamaru M; Rakugi H; Tateyama H
    Clin Cardiol; 1988 Nov; 11(11):743-7. PubMed ID: 2976625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure.
    Mitrovic V; Willenbrock R; Miric M; Seferovic P; Spinar J; Dabrowski M; Kiowski W; Marks DS; Alegria E; Dukát A; Lenz K; Arens HA
    Am Heart J; 2003 Mar; 145(3):E14. PubMed ID: 12660683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure.
    Kos T; Pacher R; Wimmer A; Bojic A; Hülsmann M; Frey B; Mayer G; Yilmaz N; Skvarilova L; Spinar J; Vitovec J; Toman J; Woloszcuk W; Stanek B
    Wien Klin Wochenschr; 1998 Feb; 110(3):89-95. PubMed ID: 9553203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytokines and remodeling of the heart in patients with congestive heart failure].
    Jołda-Mydłowska B; Salomon P
    Pol Arch Med Wewn; 2003 Jan; 109(1):23-33. PubMed ID: 12879763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.
    Cody RJ; Atlas SA; Laragh JH; Kubo SH; Covit AB; Ryman KS; Shaknovich A; Pondolfino K; Clark M; Camargo MJ
    J Clin Invest; 1986 Nov; 78(5):1362-74. PubMed ID: 2945832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of plasma catecholamines, plasma renin activity, and plasma atrial natriuretic peptide at rest and during exercise in congestive heart failure: comparison with clinical evaluation, ejection fraction, and exercise capacity.
    Madsen BK; Keller N; Christiansen E; Christensen NJ
    J Card Fail; 1995 Jun; 1(3):207-16. PubMed ID: 9420653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels.
    Nootens M; Kaufmann E; Rector T; Toher C; Judd D; Francis GS; Rich S
    J Am Coll Cardiol; 1995 Dec; 26(7):1581-5. PubMed ID: 7594089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased circulating big endothelin-1, endothelin-1 and atrial natriuretic peptide in infants and children with heart failure secondary to congenital heart disease.
    Yeh JL; Hsu JH; Dai ZK; Liou SF; Chen IJ; Wu JR
    Int J Cardiol; 2005 Sep; 104(1):15-20. PubMed ID: 16055212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm.
    Tuinenburg AE; Van Veldhuisen DJ; Boomsma F; Van Den Berg MP; De Kam PJ; Crijns HJ
    Am J Cardiol; 1998 May; 81(10):1207-10. PubMed ID: 9604948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators.
    Daggubati S; Parks JR; Overton RM; Cintron G; Schocken DD; Vesely DL
    Cardiovasc Res; 1997 Nov; 36(2):246-55. PubMed ID: 9463636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endothelin in arterial hypertension].
    Gorbacheva ON; Zharova EA; Masenko VP; Nasonov EL; Samoriadova OS; Karpov IuA
    Ter Arkh; 1991; 63(4):48-50. PubMed ID: 1829861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
    Frantz RP; Lowes BD; Grayburn PA; White M; Krause-Steinrauf H; Krishnan V; Uyeda L; Burnett JC;
    J Card Fail; 2007 Aug; 13(6):437-44. PubMed ID: 17675057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.